PCM
OPK icon

Prelude Capital Management’s Opko Health OPK Stock Holding History

Prelude Capital Management’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,200
Closed -$8K – 1792
2020
Q3 		$8K Buy
+2,200
New +$9.29K ﹤0.01% 1492
2015
Q3 		– Sell
-5,000
Closed -$80K – 1701
2015
Q2 		$80K Buy
+5,000
New +$77.8K 0.01% 966

Other funds holding OPK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Prelude Capital Management's OPK Position: Q3 2019 in Review

Prelude Capital Management sold out of Opko Health (OPK) in Q3 2019, closing a stake of 133,586 shares — an estimated $326K sold.

Prelude Capital Management first reported a position in OPK in Q2 2015 and held it in 4 quarters. The position peaked at $923K in Q2 2018. 187 funds tracked by Wall St. Rank hold OPK as of Q3 2019.

  • Prelude Capital Management reported no remaining Opko Health position as of Q3 2019 after selling out during the quarter.
  • Prelude Capital Management sold 133,586 Opko Health shares in Q3 2019, an estimated $326K.
  • Prelude Capital Management first reported a position in Opko Health in Q2 2015 and held it in 4 quarters.
  • Prelude Capital Management's Opko Health position peaked at $923K in Q2 2018.
  • 187 funds tracked by Wall St. Rank held Opko Health as of Q3 2019.

Based on Prelude Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.